Targeting ferroptosis halts graft deterioration in transplantation
Trends in Molecular Medicine · 2026
DOI: 10.1016/j.molmed.2026.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Molecular Medicine, 2026. Verfasst von Chunheng Mo. Beteiligte Einrichtung: The Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Universi…. Hauptthemen laut MEDLINE: Ferroptosis, Reperfusion Injury, Organ Transplantation, Graft Survival. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ischemia-reperfusion injury accelerates graft deterioration and limits the use of marginal donor organs. Recently, Veeckmans et al. showed that pharmacological ferroptosis inhibition preserves liver and lung graft function across porcine and human perfusion platforms, positioning lipid peroxidation-driven cell death as an actionable target in machine perfusion-era transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu 610041, China. Electronic add…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mo, C. (2026). Targeting ferroptosis halts graft deterioration in transplantation. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2026.06.005
Vancouver
Mo C. Targeting ferroptosis halts graft deterioration in transplantation. Trends in Molecular Medicine. 2026. doi:10.1016/j.molmed.2026.06.005
BibTeX
@article{Mo2026,
author = {Mo, Chunheng},
title = {Targeting ferroptosis halts graft deterioration in transplantation},
journal = {Trends in Molecular Medicine},
year = {2026},
doi = {10.1016/j.molmed.2026.06.005}
}
EUVIMED